DOSES
od /qDonce daily
bd/BID twice daily
tds /TID three times daily
qds/QID four times daily
ROUTES
im intramuscular
inh inhaled
iv intravenous
ivi intravenous infusion
neb via nebuliser
nocte at night
mane in the morning
prn as required
stat at once
po oral
pr per rectal
sc subcutaneous
top topical
sl sublingual
5-ASA
SHT
ASCE
AAC
Ab
abdo
ABPM
ACC
ACCP
ACh
ACS
ADP
Ag
AHA
AKI
ALP
ALS
5-aminosalicylic acid
5-hydroxytryptamine (z serotonin)
accident and emergency
antibiotic-associated colitis
antibody
abdomen/abdominal
ambulatory blood pressure monitoring
American College of Cardiology
American College of Chest Physicians
ACE inhibitor
acetylcholine
acute coronary syndrome
adenosine phosphate
atrial fibrillation
antigen
American Heart Association
acute kidney injury
acute lymphoblastic leukaemia
alkaline phosphatase
adult life support (algorithms of European
ALS
ALT
AMTS
ANA
ARB(s)
ARDS
AS
ASAP
assoc
AST
AV
AVM
adult life support (algorithms of European
Resuscitation Council)
alanine(-amino) transferase
acute myocardial infarction
abbreviated mental test score (same as MT S)
anti-nuclear antigens
activate partial thromboplastin time
angiotensin receptor blocker(s)
adult respiratory distress syndrome
aortic stenosis
as soon as possible
associated
aspartate transammase
arteriovenous
arteriovenous malformation
AVN
AZT
BBB
BCSH
BCT
BHS
BIH
BIPAP
BM
BMI
BPH
BTS
c
atrioventricular node
zidovudine
bundle branch block
British Committee for Standards in Haematology
broad complex tachycardia
blood flow
serum blood glucose in mmol/l; see also CBG
British Hypertension Society
benign intracranial hypertension
bilevel/biphasic positive airway pressure
bone marrow (NB: BM is often used, confusingly,
to signify finger-prick glucose; CBG (capillary blood
glucose) is used for this purpose in this book)
body mass index = weight (kg)/height (m)2
blood pressure
benign prostatic hypertrophy
British Thoracic Society
biopsy
constlpatlon
cancer (NB: calcium is abbreviated to Ca2+)
BTS
c
Ca
CAH
CBF
CBG
CCF
CCU
cf
CK
CKD
CLL
CML
CMV
CNS
British Thoracic Society
biopsy
constlpatlon
cancer (NB: calcium is abbreviated to Ca2+)
congenital adrenal hyperplasia
cerebral blood flow
capillary blood glucose in mmol/l (finger-prick testing)
(NB: BM is often used to denote this, but this is
confusing and less accurate and thus not used in
this book)
congestive cardiac failure
Coronary Care Unit
compared with
contraindicated
creatine kinase
chronic kidney disease
chronic lymphocytic leukaemia
chronic myelogenous leukaemia
cytomegalovirus
central nervous system
co
COPD
cox
CPR
CRF
CRP
CSF
CSM
CT
CVA
CVP
CXR
DA
DCT
dfx
cardiac output
chronic obstructive pulmonary disease
cyclo-oxygenase
cardiopulmonary resuscitation
chronic renal failure
C reactive protein
cerebrospinal fluid
Committee on Safety of Medicines
computerised tomography
cerebrovascular accident
central venous pressure
chest X-ray
diarrhoea
dopamine receptor subtype1/2/3
diarrhoea and vomiting
dopamine
distal convoluted tubule
defects
diabetes insipidus
DIC
DIGAMI
DKA
DMARD
dt
DWI
e'lyte
EBV
ECG
ECT
ENT
disseminated intravascular coagulation
glucose, insulin and potassium intravenous infusion
used in acute myocardial infarction
diabetic ketoacidosis
diabetes mellitus
disease-modifying anti-rheumatoid arthritis drug
due to
diffusion weighted (imaging); specialist MRI mostly
used for strokeÆIA
diagnosis
eosinophils
electrolyte
Epstein—Barr virus
electrocardiogram
electroconvulsive therapy
ejection fraction
ear, nose and throat
EPSE
ERC
ESC
ESR
exac
FBC
FFP
FHx
Fi02
FMF
fx
G6PD
GABA
GBS
GCS
GFR
GI
GIK
extrapyramidal side effects
European Resuscitation Council
European Society of Cardiology
erythrocyte sedimentation rate
exacerbates
full blood count
iron
fresh frozen plasma
family history
inspired 02 concentration
familial Mediterranean fever
effects
glucose-6-phosphate dehydrogenase
gamma aminobutyric acid
Guillain—Barré syndrome
Glasgow Coma Scale
glomerular filtration rate
gastrointestinal
glucose, insulin and K + infusion
GFR
GI
GIK
GMC
GTN
GU
HBPM
Hct
HDL
HIV
FILA
HMG-CoA
HONK
hrly
glomerular filtration rate
gastrointestinal
glucose, insulin and K + infusion
General Medical Council (of UK)
glyceryl trinitrate
genitourinary
hour(s)
hypertrophic (obstructive) cardiomyopathy
haemoglobin
heart block
home blood pressure monitoring
haematocrit
high-density lipoprotein
heart failure
human immunodeficiency virus
human leucocyte antigen
3-hydroxy-3-methyl-glutaryl coenzyme A
hyperosmolar non-ketotic state
hourly
HSV
HTN
HUS
IBD
IBS
IBW
ICP
ICU
IHD
IL-2
Inc
inh
INR
IOP
herpes simplex virus
height
hypertension
haemolytic uraemic syndrome
history
inflammatory bowel disease
irritable bowel syndrome
ideal body weight (see p. 268 for details)
intracranial pressure
intensrve care unit
ischaemic heart disease
interleukin-2
intramuscular
including
inhaled
international normalised ratio (prothrombin ratio)
intraocular pressure
immune/idiopathic thrombocytopenic purpura
intensive therapy unit
intravenous
iv
IVDU
ivi
Ix
LA
LBBB
LDL
LF
LFTs
LMWH
LVF
mane
immune/idiopathic thrombocytopenic purpura
intensive therapy unit
intravenous
intravenous drug user
intravenous infusion
Investigation
potassium (serum levels unless stated otherwise)
lymphocytes
long-acting
left bundle branch block
low-density lipoprotein
liver failure
liver function tests
low-molecular-weight heparin
lumbar puncture
left ventricular failure
macrophages
m mormng
Preface ▼xiii
About the authors ▼xvii
Contributors ▼xix
ABCD2 scoring system ▼1
ACE inhibitor-induced cough ▼2
Acetylcysteine for nebulisation ▼3
Acute kidney injury ▼4
Addison’s disease ▼7
Adrenaline: nebulised ▼9
Adverse drug reactions ▼10
Anaemias ▼20
Angioedema: drug causes and treatment ▼25
Antibiotic choice ▼27
Antimicrobial allergy management ▼28
Antiphospholipid syndrome ▼30
Antipsychotics: equivalent doses ▼32
Apomorphine ▼33
Appetite stimulation ▼36
Arterial blood gases and acid–base balance ▼38
Artificial saliva ▼39
Asthma ▼41
Atrial fibrillation ▼47
Bariatric surgery ▼54
Benzodiazepines and ‘z’ hypnotics ▼57
Bicarbonate ▼59
Body surface area calculation ▼61
Bronchiectasis (non-cystic fibrosis) ▼65
Calcium ▼68
Carbamazepine ▼71
Chemotherapy-induced nausea and vomiting ▼74
Child–Pugh score ▼75
Chloramphenicol (systemic) ▼76
Chronic obstructive pulmonary disease ▼79
vii
CPPC ftoc.tex V1 - 11/18/2015 1:59 P.M. Page viii ❦
❦ ❦
❦
Ciclosporin: management and monitoring ▼83
Cigarette smoking: calculation of pack-years ▼86
Cigarette smoking –drug interactions ▼87
Clozapine ▼88
Cognitive assessment
CPPC ftoc.tex V1 - 11/18/2015 1:59 P.M. Page ix ❦
❦ ❦
❦
Falls: pharmaceutical care ▼173
Ferinject ▼176
Fluid balance ▼177
Food–drug interactions ▼182
Gastrointestinal bleeding risk management ▼184
Gentamicin ▼185
Glasgow Coma Scale ▼190
Glucosamine ▼192
Grapefruit juice –drug interactions ▼194
Human immunodeficiency virus treatment ▼197
Hyperosmolar hyperglycaemic state ▼208
Hypodermoclysis ▼211
Hypopituitarism ▼213
Ideal body weight ▼216
Immunoglobulin (normal) for intravenous administration ▼216
Inflammatory bowel disease ▼219
Inhaler devices in respiratory disease ▼223
Insulins ▼224
Insulin: variable-rate intravenous insulin infusion ▼231
Interstitial lung disease ▼233
Iron: guidance on parenteral dosing and administration ▼238
Kidney stones (renal calculi) ▼241
Lactose-free medicines ▼243
Learning disability: caring for people with learning disability and
other vulnerable patients ▼244
LipidRescue ▼248
Lithium: management and monitoring ▼249
Liver disease (chronic) ▼253
Liver function tests ▼259
Low-molecular-weight heparin ▼262
Magnesium ▼264
Medicines reconciliation ▼268
Methotrexate: calcium folinate rescue regimen ▼270
Monofer ▼272
Mouth ulcers and sore mouth ▼273
Multiple sclerosis: symptomatic management ▼274
Nausea and vomiting ▼278
Neuroleptic malignant syndrome ▼279
Neutropenic sepsis ▼280
CONTENTS ix
CPPC ftoc.tex V1 - 11/18/2015 1:59 P.M. Page x ❦
❦ ❦
❦
Nicotine replacement therapy ▼282
‘Nil-by-mouth’: management of long-term medicines during
surgery ▼284
Nutraceuticals for eye health ▼289
Omeprazole: parenteral administration ▼292
Oncological emergencies ▼296
Opioid comparative doses ▼297
Opioid misuse management ▼298
Opioid partial agonists ▼303
Osteoporosis ▼303
Oxygen ▼308
Pain management ▼311
Palliative and end-of-life care ▼318
Pancreatitis ▼327
Parenteral nutrition: a practical overview ▼331
Patient consultation ▼334
Patient-controlled analgesia ▼339
Phaeochromocytoma ▼341
Pharmacocultural issues ▼343
Phenytoin: management and monitoring ▼345
Phosphate ▼349
Postoperative nausea and vomiting ▼352
Potassium ▼355
Prescription charge exemptions and prepayment certificates ▼360
Protamine ▼361
Prothrombin complex concentrates ▼362
Pulmonary function tests ▼363
Pulmonary hypertension and pulmonary arterial
hypertension ▼368
Quinine for muscle cramps ▼373
Rapid tranquillisation ▼375
Renal disease: assessment of renal function ▼379
Renal disease: dosing in renal impairment and renal replacement
therapy ▼382
Renal disease: chronic kidney disease ▼386
Renal replacement therapy: haemodialysis ▼393
Renal replacement therapy: haemofiltration ▼396
Renal replacement therapy: peritoneal dialysis ▼398
Rheumatoid arthritis: drugs suppressing the disease process ▼400
x CONTENTS
CPPC ftoc.tex V1 - 11/18/2015 1:59 P.M. Page xi ❦
❦ ❦
❦
Rockall score for gastrointestinal bleed ▼411
Sarcoidosis ▼412
Sclerosants for the management of malignant pleural
effusions ▼415
Serotonin syndrome ▼416
Systemic inflammatory response syndrome due to sepsis scoring
system ▼418
Sodium ▼420
Sterile larvae ▼422
Stroke and transient ischaemic attack ▼424
Suppositories ▼433
Surgical pharmacy ▼434
Synacthen (tetracosactide) tests ▼440
Syndrome of inappropriate secretion of antidiuretic hormone ▼442
Syringe pumps ▼443
Theophylline ▼447
Thunderclap headache ▼450
Thyroid function ▼450
Tinzaparin dosing in pulmonary embolism and deep-vein
thrombosis ▼454
Tobramycin: monitoring and management ▼455
Travel recommendations ▼458
Tuberculosis ▼459
Vancomycin ▼470
Venofer ▼474
Vitamins and minerals ▼474
von Willebrand disease ▼484
Warfarin treatment and monitoring ▼486
Wells score for deep-vein thrombosis ▼494
Wells score for pulmonary embolism ▼495
Yellow Card scheme ▼497
Zinc
od /qDonce daily
bd/BID twice daily
tds /TID three times daily
qds/QID four times daily
ROUTES
im intramuscular
inh inhaled
iv intravenous
ivi intravenous infusion
neb via nebuliser
nocte at night
mane in the morning
prn as required
stat at once
po oral
pr per rectal
sc subcutaneous
top topical
sl sublingual
5-ASA
SHT
ASCE
AAC
Ab
abdo
ABPM
ACC
ACCP
ACh
ACS
ADP
Ag
AHA
AKI
ALP
ALS
5-aminosalicylic acid
5-hydroxytryptamine (z serotonin)
accident and emergency
antibiotic-associated colitis
antibody
abdomen/abdominal
ambulatory blood pressure monitoring
American College of Cardiology
American College of Chest Physicians
ACE inhibitor
acetylcholine
acute coronary syndrome
adenosine phosphate
atrial fibrillation
antigen
American Heart Association
acute kidney injury
acute lymphoblastic leukaemia
alkaline phosphatase
adult life support (algorithms of European
ALS
ALT
AMTS
ANA
ARB(s)
ARDS
AS
ASAP
assoc
AST
AV
AVM
adult life support (algorithms of European
Resuscitation Council)
alanine(-amino) transferase
acute myocardial infarction
abbreviated mental test score (same as MT S)
anti-nuclear antigens
activate partial thromboplastin time
angiotensin receptor blocker(s)
adult respiratory distress syndrome
aortic stenosis
as soon as possible
associated
aspartate transammase
arteriovenous
arteriovenous malformation
AVN
AZT
BBB
BCSH
BCT
BHS
BIH
BIPAP
BM
BMI
BPH
BTS
c
atrioventricular node
zidovudine
bundle branch block
British Committee for Standards in Haematology
broad complex tachycardia
blood flow
serum blood glucose in mmol/l; see also CBG
British Hypertension Society
benign intracranial hypertension
bilevel/biphasic positive airway pressure
bone marrow (NB: BM is often used, confusingly,
to signify finger-prick glucose; CBG (capillary blood
glucose) is used for this purpose in this book)
body mass index = weight (kg)/height (m)2
blood pressure
benign prostatic hypertrophy
British Thoracic Society
biopsy
constlpatlon
cancer (NB: calcium is abbreviated to Ca2+)
BTS
c
Ca
CAH
CBF
CBG
CCF
CCU
cf
CK
CKD
CLL
CML
CMV
CNS
British Thoracic Society
biopsy
constlpatlon
cancer (NB: calcium is abbreviated to Ca2+)
congenital adrenal hyperplasia
cerebral blood flow
capillary blood glucose in mmol/l (finger-prick testing)
(NB: BM is often used to denote this, but this is
confusing and less accurate and thus not used in
this book)
congestive cardiac failure
Coronary Care Unit
compared with
contraindicated
creatine kinase
chronic kidney disease
chronic lymphocytic leukaemia
chronic myelogenous leukaemia
cytomegalovirus
central nervous system
co
COPD
cox
CPR
CRF
CRP
CSF
CSM
CT
CVA
CVP
CXR
DA
DCT
dfx
cardiac output
chronic obstructive pulmonary disease
cyclo-oxygenase
cardiopulmonary resuscitation
chronic renal failure
C reactive protein
cerebrospinal fluid
Committee on Safety of Medicines
computerised tomography
cerebrovascular accident
central venous pressure
chest X-ray
diarrhoea
dopamine receptor subtype1/2/3
diarrhoea and vomiting
dopamine
distal convoluted tubule
defects
diabetes insipidus
DIC
DIGAMI
DKA
DMARD
dt
DWI
e'lyte
EBV
ECG
ECT
ENT
disseminated intravascular coagulation
glucose, insulin and potassium intravenous infusion
used in acute myocardial infarction
diabetic ketoacidosis
diabetes mellitus
disease-modifying anti-rheumatoid arthritis drug
due to
diffusion weighted (imaging); specialist MRI mostly
used for strokeÆIA
diagnosis
eosinophils
electrolyte
Epstein—Barr virus
electrocardiogram
electroconvulsive therapy
ejection fraction
ear, nose and throat
EPSE
ERC
ESC
ESR
exac
FBC
FFP
FHx
Fi02
FMF
fx
G6PD
GABA
GBS
GCS
GFR
GI
GIK
extrapyramidal side effects
European Resuscitation Council
European Society of Cardiology
erythrocyte sedimentation rate
exacerbates
full blood count
iron
fresh frozen plasma
family history
inspired 02 concentration
familial Mediterranean fever
effects
glucose-6-phosphate dehydrogenase
gamma aminobutyric acid
Guillain—Barré syndrome
Glasgow Coma Scale
glomerular filtration rate
gastrointestinal
glucose, insulin and K + infusion
GFR
GI
GIK
GMC
GTN
GU
HBPM
Hct
HDL
HIV
FILA
HMG-CoA
HONK
hrly
glomerular filtration rate
gastrointestinal
glucose, insulin and K + infusion
General Medical Council (of UK)
glyceryl trinitrate
genitourinary
hour(s)
hypertrophic (obstructive) cardiomyopathy
haemoglobin
heart block
home blood pressure monitoring
haematocrit
high-density lipoprotein
heart failure
human immunodeficiency virus
human leucocyte antigen
3-hydroxy-3-methyl-glutaryl coenzyme A
hyperosmolar non-ketotic state
hourly
HSV
HTN
HUS
IBD
IBS
IBW
ICP
ICU
IHD
IL-2
Inc
inh
INR
IOP
herpes simplex virus
height
hypertension
haemolytic uraemic syndrome
history
inflammatory bowel disease
irritable bowel syndrome
ideal body weight (see p. 268 for details)
intracranial pressure
intensrve care unit
ischaemic heart disease
interleukin-2
intramuscular
including
inhaled
international normalised ratio (prothrombin ratio)
intraocular pressure
immune/idiopathic thrombocytopenic purpura
intensive therapy unit
intravenous
iv
IVDU
ivi
Ix
LA
LBBB
LDL
LF
LFTs
LMWH
LVF
mane
immune/idiopathic thrombocytopenic purpura
intensive therapy unit
intravenous
intravenous drug user
intravenous infusion
Investigation
potassium (serum levels unless stated otherwise)
lymphocytes
long-acting
left bundle branch block
low-density lipoprotein
liver failure
liver function tests
low-molecular-weight heparin
lumbar puncture
left ventricular failure
macrophages
m mormng
MAOI
MAP
MCA
MCV
metab
MG
MHRA
MI
MMF
MMSE
MR
MRI
MRSA
MS
MTS
MUST
monoamine oxidase inhibitor
mean arterial pressure
middle cerebral artery
mean corpuscular volume
metabolised
myasthenia gravis
Medicines and Healthcare Products Regulatory
Authority (UK)
myocardial infarction
mycophenolate mofetil
Mini-Nlental State Examination (scored out of 30* )
modified release (drug preparation)t
magnetic resonance magmg
methicillin-resistant Staphylococcus aureus
multiple sclerosis
(abbreviated) Mental Test Score (scored out of 10* )
malnutrition universal screening tool
management
nausea
NA
NBM
NCT
NDRI
neb
NGT
NH
NIDDM
NIHSS
NIV
NMJ
NMS
NPIS
NSAID
nausea and vomiting
neutrophils
noradrenaline (norepinephrine)
sodium (serum levels unless stated otherwise)
nil by mouth
narrow complex tachycardia
noradrenaline and dopamine reuptake inhibitor
via nebuliser
nasogastric tube
non-Hodgkin's (lymphoma)
non-insulin-dependent diabetes mellitus
National (US) Institute of Health Stroke Scale
non-invasive ventilation
neuromuscular junction
neuroleptic malignant syndrome
National Poisons Information Service
non-steroidal anti-inflammatory drug
NSTEMI
NYHA
OCD
ocp
OD
OGD
p'way(s)
PAN
PBC
PCI
PCOS
PCP
PCV
PDA
PEA
PEG
non-ST elevation myocardial infarction
New York Heart Association
obsessive compulsive disorder
oral contraceptive pill
overdose (NB: od once daily!)
oesophagogastroduodenoscopy
pathway(s)
polyarteritis nodosa
primary biliary cirrhosis
percutaneous coronary intervention (now preferred
term for percutaneous transluminal coronary
angioplasty (P T CA), which is a subtype of PCI)
polycystic ovary syndrome
Pneumocystis carinii pneumonia
packed cell volume
patent ductus arteriosus
pulmonary embolism
pulseless electrical activity
percutaneous endoscopic gastrostomy
PDA
PEA
PEG
PG(x)
phaeo
PHx
PID
PML
PMR
P04
PPI
pr
prep(s)
prn
PSA
PT
PTSD
patent ductus arteriosus
pulmonary embolism
pulseless electrical activity
percutaneous endoscopic gastrostomy
prostaglandin (receptor subtype x)
phaeochromocytoma
past history (of)
pelvic inflammatory disease
progressive multifocal leukoencephalopathy
polymyalgia rheumatica
by mouth (oral)
phosphate (serum levels, unless stated otherwise)
proton pump inhibitor
rectal
preparation(s)
as required
prostate specific antigen
platelet(s)
prothrombin time
parathyroid hormone
post-traumatic stress disorder
PUO
PVD
QT(c)
RAS
RBF
RLS
ROSIER
RRT
RSV
RTI
RV
RVF
peptic ulcer
pyrexia of unknown origin
peripheral vascular disease
prophylaxis
QT interval (corrected for rate)
rheumatoid arthritis
renal artery stenosis
renal blood flow
renal failure
restless legs syndrome
recognition of stroke in emergency room scale for
diagnosis of stroke/TIA
respiratory rate
renal replacement therapy
respiratory syncytial virus
respiratory tract infection
right ventricle
right ventricular failure
treatment
SAH
SAN
SBE
SE(s)
SIADH
SIGN
SJS
sl
SLE
SOA
SOB (OE)
SPC
SPP
SR
subarachnoid haemorrhage
sinoatrial node
subacute bacterial endocarditis
subcutaneous
side effect(s)
second(s)
syndrome of inappropriate antidiuretic hormone
Scottish Intercollegiate Guidelines Network
Stevens—Johnson syndrome
sublingual
systemic lupus erythematosus
swelling of ankles
shortness of breath (on exertion)
summary of product characteristic sheet (see page viii)
specles
slow/sustained release (drug preparation)
SSRI
sss
STEMI
supp
SVT
tl,'2
TCA
TEDS
TEN
TFTs
TIBC
TIMI score
TNF
top
selective serotonin reuptake inhibitor
sick sinus syndrome
ST elevation myocardial infarction
suppository
supraventricular tachycardia
half-life
triiodothyronine/liothyronine
thyroxine (T/JT4 = hyper/hypothyroid)
tricyclic antidepressant
thromboembolism
thromboembolism deterrent stockings
toxic epidermal necrolysis
thyroid function tests
triglyceride
total iron binding capacity
risk score for UA/NSTEMI named after TIMI
(thrombolysis in MI) trial
tumour necrosis factor
topical
TPMT
TPR
ITA(s)
TT0(s)
U&Es
UA(P)
UC
URTI
VE(s)
Vlt
thiopurine methyltransferase
total peripheral resistance
(drugs) to take away, i.e. prescriptions for inpatients
on discharge/leave (aka HO)
see ITA
thrombotic thrombocytopenic purpura
urea and electrolytes
unstable angina (pectoris)
ulcerative colitis
upper respiratory tract infection
urinary tract infection
ultraviolet
vomltlng
ventricular ectopic(s)
ventricular fibrillation
vrtamm
VLDL
VTE
vzv
w/o
wcc
wk
wkly
WPW
Wt
xs
ZE
very-low-density lipoprotein
ventricular tachycardia
venous thromboembolism
varicella zoster virus (chickenpox/shingles)
with
within
without
white cell count
Wernicke's encephalopathy
week
weekly
Wolff—Parkinson—White syndrome
weight
excess
Zollinger—Ellison syndrome
About the authors ▼xvii
Contributors ▼xix
ABCD2 scoring system ▼1
ACE inhibitor-induced cough ▼2
Acetylcysteine for nebulisation ▼3
Acute kidney injury ▼4
Addison’s disease ▼7
Adrenaline: nebulised ▼9
Adverse drug reactions ▼10
Anaemias ▼20
Angioedema: drug causes and treatment ▼25
Antibiotic choice ▼27
Antimicrobial allergy management ▼28
Antiphospholipid syndrome ▼30
Antipsychotics: equivalent doses ▼32
Apomorphine ▼33
Appetite stimulation ▼36
Arterial blood gases and acid–base balance ▼38
Artificial saliva ▼39
Asthma ▼41
Atrial fibrillation ▼47
Bariatric surgery ▼54
Benzodiazepines and ‘z’ hypnotics ▼57
Bicarbonate ▼59
Body surface area calculation ▼61
Bronchiectasis (non-cystic fibrosis) ▼65
Calcium ▼68
Carbamazepine ▼71
Chemotherapy-induced nausea and vomiting ▼74
Child–Pugh score ▼75
Chloramphenicol (systemic) ▼76
Chronic obstructive pulmonary disease ▼79
vii
CPPC ftoc.tex V1 - 11/18/2015 1:59 P.M. Page viii ❦
❦ ❦
❦
Ciclosporin: management and monitoring ▼83
Cigarette smoking: calculation of pack-years ▼86
Cigarette smoking –drug interactions ▼87
Clozapine ▼88
Cognitive assessment
CPPC ftoc.tex V1 - 11/18/2015 1:59 P.M. Page ix ❦
❦ ❦
❦
Falls: pharmaceutical care ▼173
Ferinject ▼176
Fluid balance ▼177
Food–drug interactions ▼182
Gastrointestinal bleeding risk management ▼184
Gentamicin ▼185
Glasgow Coma Scale ▼190
Glucosamine ▼192
Grapefruit juice –drug interactions ▼194
Human immunodeficiency virus treatment ▼197
Hyperosmolar hyperglycaemic state ▼208
Hypodermoclysis ▼211
Hypopituitarism ▼213
Ideal body weight ▼216
Immunoglobulin (normal) for intravenous administration ▼216
Inflammatory bowel disease ▼219
Inhaler devices in respiratory disease ▼223
Insulins ▼224
Insulin: variable-rate intravenous insulin infusion ▼231
Interstitial lung disease ▼233
Iron: guidance on parenteral dosing and administration ▼238
Kidney stones (renal calculi) ▼241
Lactose-free medicines ▼243
Learning disability: caring for people with learning disability and
other vulnerable patients ▼244
LipidRescue ▼248
Lithium: management and monitoring ▼249
Liver disease (chronic) ▼253
Liver function tests ▼259
Low-molecular-weight heparin ▼262
Magnesium ▼264
Medicines reconciliation ▼268
Methotrexate: calcium folinate rescue regimen ▼270
Monofer ▼272
Mouth ulcers and sore mouth ▼273
Multiple sclerosis: symptomatic management ▼274
Nausea and vomiting ▼278
Neuroleptic malignant syndrome ▼279
Neutropenic sepsis ▼280
CONTENTS ix
CPPC ftoc.tex V1 - 11/18/2015 1:59 P.M. Page x ❦
❦ ❦
❦
Nicotine replacement therapy ▼282
‘Nil-by-mouth’: management of long-term medicines during
surgery ▼284
Nutraceuticals for eye health ▼289
Omeprazole: parenteral administration ▼292
Oncological emergencies ▼296
Opioid comparative doses ▼297
Opioid misuse management ▼298
Opioid partial agonists ▼303
Osteoporosis ▼303
Oxygen ▼308
Pain management ▼311
Palliative and end-of-life care ▼318
Pancreatitis ▼327
Parenteral nutrition: a practical overview ▼331
Patient consultation ▼334
Patient-controlled analgesia ▼339
Phaeochromocytoma ▼341
Pharmacocultural issues ▼343
Phenytoin: management and monitoring ▼345
Phosphate ▼349
Postoperative nausea and vomiting ▼352
Potassium ▼355
Prescription charge exemptions and prepayment certificates ▼360
Protamine ▼361
Prothrombin complex concentrates ▼362
Pulmonary function tests ▼363
Pulmonary hypertension and pulmonary arterial
hypertension ▼368
Quinine for muscle cramps ▼373
Rapid tranquillisation ▼375
Renal disease: assessment of renal function ▼379
Renal disease: dosing in renal impairment and renal replacement
therapy ▼382
Renal disease: chronic kidney disease ▼386
Renal replacement therapy: haemodialysis ▼393
Renal replacement therapy: haemofiltration ▼396
Renal replacement therapy: peritoneal dialysis ▼398
Rheumatoid arthritis: drugs suppressing the disease process ▼400
x CONTENTS
CPPC ftoc.tex V1 - 11/18/2015 1:59 P.M. Page xi ❦
❦ ❦
❦
Rockall score for gastrointestinal bleed ▼411
Sarcoidosis ▼412
Sclerosants for the management of malignant pleural
effusions ▼415
Serotonin syndrome ▼416
Systemic inflammatory response syndrome due to sepsis scoring
system ▼418
Sodium ▼420
Sterile larvae ▼422
Stroke and transient ischaemic attack ▼424
Suppositories ▼433
Surgical pharmacy ▼434
Synacthen (tetracosactide) tests ▼440
Syndrome of inappropriate secretion of antidiuretic hormone ▼442
Syringe pumps ▼443
Theophylline ▼447
Thunderclap headache ▼450
Thyroid function ▼450
Tinzaparin dosing in pulmonary embolism and deep-vein
thrombosis ▼454
Tobramycin: monitoring and management ▼455
Travel recommendations ▼458
Tuberculosis ▼459
Vancomycin ▼470
Venofer ▼474
Vitamins and minerals ▼474
von Willebrand disease ▼484
Warfarin treatment and monitoring ▼486
Wells score for deep-vein thrombosis ▼494
Wells score for pulmonary embolism ▼495
Yellow Card scheme ▼497
Zinc
No comments:
Post a Comment